IP Verse

Monosol Rx competitive analysis

Latest PTAB cases involving Monosol Rx

Discover the latest PTAB cases involving Monosol Rx, highlighting their recent legal challenges and patent disputes.

Last updated on: Feb 1, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Monosol Rx

IPR2017-01949Aug 15, 2017MYLANMONOSOL RXTerminated-Settled
IPR2017-01582Jun 12, 2017DR REDDYS LABORATORIESMONOSOL RXInstitution Denied
IPR2017-01557Jun 9, 2017PAR PHARMACEUTICALMONOSOL RXInstitution Denied
IPR2017-00412Dec 6, 2016MONOSOL RXICOSInstitution Denied
IPR2017-00200Nov 4, 2016MYLANMONOSOL RXTerminated-Settled
IPR2016-01111May 31, 2016DR REDDYS LABORATORIESMONOSOL RXInstitution Denied
IPR2016-01112May 31, 2016DR REDDYS LABORATORIESMONOSOL RXInstitution Denied
IPR2016-00281Dec 4, 2015TEVA PHARMACEUTICALSMONOSOL RXInstitution Denied
IPR2016-00282Dec 4, 2015TEVA PHARMACEUTICALSMONOSOL RXInstitution Denied
IPR2015-00165Oct 28, 2014BIODELIVERY SCIENCESMONOSOL RXTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Monosol Rx with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MONOSOL RX - - 215
BIODELIVERY SCIENCES - - 9 -
DR REDDYS LABORATORIES9627 -
MYLAN - 25 -